Chondrosarcoma: Difference between revisions

No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 13: Line 13:


==Differential Diagnosis==
==Differential Diagnosis==
 
{{Bone tumors and their mimics DDX}}
===Malignant===
*[[Multiple myeloma]]
*[[Osteosarcoma]]
*[[Paget disease]]
*[[Ewing sarcoma]]
*[[Giant cell tumor]]
*[[Adamantinoma]]
*[[Chordoma]]
*[[Primary bone lymphoma]]
*Fibrosarcoma
*Myosarcoma
 
===Benign===
*[[Chrondroblastoma]]
*[[Enchondroma]]
*[[Langerhans cell histiocytosis of bone]]
*[[Osteoblastoma]]
*[[Osteochondroma]]
*[[Osteoid Osteoma]]


==Evaluation==
==Evaluation==
[[File:Mrichondrosarcoma.jpg|thumb|MRI of a left-pelvis with chondrosarcoma]]
*Plain radiographs reveal punctate calcifications and cortical bone destruction
*Plain radiographs reveal punctate calcifications and cortical bone destruction
*CT or MRI to assess extent of bone involvement
*CT or MRI to assess extent of bone involvement
Line 48: Line 30:
==References==
==References==
<references/>
<references/>
[[Category:Orthopedics]]
[[Category:Heme/Onc]]

Latest revision as of 01:12, 22 October 2020

Background[1]

Pathophysiology

  • Overproduction of chondroid matrix in the medullary cavity

Clinical Features

  • Lesions commonly in the pelvis and central skeleton
  • Occurs in patients over 40 years-old with a male predominance
  • Often will present with local swelling and pain or a pathologic fracture
  • Very slow growing tumors

Differential Diagnosis

Bone tumors and their mimics

Malignant

Benign

Other

Evaluation

MRI of a left-pelvis with chondrosarcoma
  • Plain radiographs reveal punctate calcifications and cortical bone destruction
  • CT or MRI to assess extent of bone involvement
  • Bone biopsy for definitive diagnosis

Management

  • Surgery is the definitive treatment
  • Radiation and chemotherapy are ineffective as tumor is very slow growing

Disposition

  • Home with outpatient follow up

References

  1. Niederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8.